FGFR2 and skeletal dysplasia: Although neither of these loci reaches genome-wide significance, mutations in either FGFR2 or PAPSS2 have been reported to result in different types of bone diseases such as skeletal dysplasia and craniosynostosis11, 12, 13, 14, 15.